Aspira Women's Health Inc.
AWHL· OTC
Released Mar 22, 2023, after the close
10-K filed Mar 30, 2023, 89 days after period end · 0000926617-23-000026
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.15M | $1.85M | $1.45M | $1.31M |
| Net Income | -$4.59M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$8.96M |
| -$6.08M |
| -$3.39M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.